胸横肌平面阻滞在心脏手术中的初步可行性研究
本研究为双盲预试验,评估胸横肌平面(TTP)阻滞作为心脏手术胸骨正中切开术后镇痛辅助手段的可行性。19例患者随机分入阻滞组或对照组,阻滞组在超声引导下双侧注射20 mL 0.3%或0.5%罗哌卡因。招募率95%,依从率94%,无阻滞相关不良事件;12小时静息NRS评分阻滞组3.3(3.2) vs 对照组5.6(3.2),24小时两组均为4.1。
要点
- TTP阻滞在心脏手术后镇痛中可行,招募率和依从性高。
- 无阻滞相关不良事件,初步支持安全性。
- 12小时静息疼痛评分阻滞组低于对照组,24小时无差异。
核心结论
- TTP阻滞是胸骨正中切开术后一种新颖的镇痛策略,可行性高且初步安全。
研究设计与样本
- 双盲预试验,18-90岁择期心脏手术患者随机分入阻滞组或标准护理对照组。
- 阻滞组在超声引导下双侧注射20 mL 0.3%或0.5%罗哌卡因(基于体重),对照组不注射。
- 主要可行性结局为招募率、依从性和不良事件率;次要结局包括12和24小时NRS疼痛评分、24小时氢吗啡酮和对乙酰氨基酚用量、拔管时间、首次阿片类药物给药时间和24小时患者满意度。
主要发现
- 招募率95%(19/20),治疗组依从率94%,无阻滞相关不良事件。
- 12小时静息NRS疼痛评分均值(SD):阻滞组3.3(3.2) vs 对照组5.6(3.2)。
- 24小时静息NRS疼痛评分均值(SD):阻滞组4.1(3.9) vs 对照组4.1(3.3)。
- 24小时氢吗啡酮用量均值(SD):阻滞组1.9(1.1) mg vs 对照组1.8(0.9) mg。
临床怎么用
- TTP阻滞可作为心脏手术胸骨正中切开术后镇痛的辅助手段,需进一步大样本研究验证。
局限性
- 预试验样本量小(19例),主要评估可行性,疗效结论需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Cardiac surgery patients often experience significant pain after median sternotomy. The transversus thoracis muscle plane (TTP) block is a newly developed, single-shot nerve block technique that provides analgesia for the anterior chest wall. In this double-blind pilot study, we assessed the feasibility of performing this novel block as an analgesic adjunct. METHODS: All patients aged 18-90 undergoing elective cardiac surgery were randomized to the block or standard care control group on admission to the intensive care unit after surgery. Under ultrasound guidance, patients in the block group received the TTP block with 20 mL of either 0.3% or 0.5% ropivacaine bilaterally, based on weight. The control group did not receive any injections. All blocks were performed by a single anesthesiologist, and data collection was performed by blinded assessors. The primary feasibility outcomes were rate of recruitment, adherence, and adverse events. The rate of recruitment was defined as the ratio of patients giving informed consent to the number of eligible patients who were approached to participate. Secondary outcomes included 12-hour and 24-hour Numeric Rating Scale (NRS) pain scores, 24-hour hydromorphone and acetaminophen requirements, time to extubation, time to first opioid administration, and patient satisfaction (on a yes/no questionnaire) at 24 hours. RESULTS: Twenty patients were approached for this study and 19 were enrolled. Eight patients received the intended intervention in each group. The recruitment rate was 95% of all approached eligible patients, and the adherence rate to treatment group was 94%. There were no block-related adverse events. The mean (SD) NRS pain scores at rest were 3.3 (3.2) in the block group vs 5.6 (3.2) in the control group at 12 hours. At 24 hours, the pain scores were 4.1 (3.9) vs 4.1 (3.3) in the block and control group, respectively. The mean (SD) 24-hour hydromorphone administration was 1.9 (1.1) mg in the block group vs 1.8 (0.9) mg in the control group. DISCUSSION: The TTP block is a novel pain management strategy poststernotomy. The results reveal a high patient recruitment, adherence, and satisfaction rate, and provide some preliminary data supporting safety. TRIAL REGISTRATION NUMBER: NCT03128346.
引用
- Fujii S, Roche M, Jones PM, et al. Transversus thoracis muscle plane block in cardiac surgery: a pilot feasibility study. Reg Anesth Pain Med. 2019. PMID: 30902911. doi:10.1136/rapm-2018-100178
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。